V Blanchette

Summary

Affiliation: The Hospital for Sick Children
Country: Canada

Publications

  1. ncbi request reprint Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura
    V Blanchette
    Division of Hematology Oncology, Hospital for Sick Children, Toronto, Canada
    Transfus Sci 19:279-88. 1998
  2. doi request reprint Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)
    A R Langley
    Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON
    Haemophilia 21:469-76. 2015
  3. doi request reprint A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children
    M W Chan
    Departments of Diagnostic Imaging, Hospital for Sick Children, Toronto, Canada
    Haemophilia 19:e324-34. 2013
  4. doi request reprint Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study
    P Hilliard
    Department of Rehabilitation Services, Hospital for Sick Children, University of Toronto, Toronto, Canada
    J Thromb Haemost 11:460-6. 2013
  5. doi request reprint Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A
    V Crivianu-Gaita
    Department of Chemistry, University of Toronto, Toronto, ON, Canada
    Haemophilia 22:e401-5. 2016
  6. doi request reprint Intracranial haemorrhage in von Willebrand disease: a report on six cases
    V Labarque
    Division of Haematology Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
    Haemophilia 19:602-6. 2013
  7. doi request reprint Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients
    V S Blanchette
    Hospital for Sick Children, University of Toronto, ON, Canada
    J Thromb Haemost 6:1319-26. 2008
  8. doi request reprint The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity
    S Revel-Vilk
    Department of Nursing, The Hospital for Sick Children, Toronto, Ontario, Canada
    Haemophilia 17:689-94. 2011

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura
    V Blanchette
    Division of Hematology Oncology, Hospital for Sick Children, Toronto, Canada
    Transfus Sci 19:279-88. 1998
    ..Studies are required to define the short and longer term effects of both IVIG and anti-D on the immune system in order to plan more rational use of these immunomodulatory therapies in this model autoimmune disorder...
  2. doi request reprint Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)
    A R Langley
    Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON
    Haemophilia 21:469-76. 2015
    ..While CVADs provide reliable venous access, complications such as infection and thrombosis may occur...
  3. doi request reprint A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children
    M W Chan
    Departments of Diagnostic Imaging, Hospital for Sick Children, Toronto, Canada
    Haemophilia 19:e324-34. 2013
    ..However, there is no evidence that screening of early intra-articular soft tissue bleed with MRI improves the functional status of joints over time...
  4. doi request reprint Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study
    P Hilliard
    Department of Rehabilitation Services, Hospital for Sick Children, University of Toronto, Toronto, Canada
    J Thromb Haemost 11:460-6. 2013
    ..Full-dose prophylaxis is very effective at minimizing joint damage but is costly. Tailored prophylaxis has been proposed as a way of reducing costs while still protecting joints...
  5. doi request reprint Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A
    V Crivianu-Gaita
    Department of Chemistry, University of Toronto, Toronto, ON, Canada
    Haemophilia 22:e401-5. 2016
    ..According to pharmacokinetic principles, daily factor infusions of smaller doses can maintain similar trough factor VIII (FVIII) levels, and perhaps the same protection as standard prophylaxis...
  6. doi request reprint Intracranial haemorrhage in von Willebrand disease: a report on six cases
    V Labarque
    Division of Haematology Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
    Haemophilia 19:602-6. 2013
    ..A much larger cohort of patients with VWD experiencing an ICH is needed to make recommendations regarding treatment of such events, including the role of prophylaxis in patients with more severe forms of VWD...
  7. doi request reprint Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients
    V S Blanchette
    Hospital for Sick Children, University of Toronto, ON, Canada
    J Thromb Haemost 6:1319-26. 2008
    ..The pharmacokinetics of factor VIII replacement therapy in preschool previously treated patients (PTPs) with hemophilia A have not been well characterized...
  8. doi request reprint The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity
    S Revel-Vilk
    Department of Nursing, The Hospital for Sick Children, Toronto, Ontario, Canada
    Haemophilia 17:689-94. 2011
    ..Overweight and obese haemophilic boys should be evaluated for NAFLD and interventional programmes should be designed to reduce the potential complications associated with obesity...